Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy
Open Access
- 8 April 2021
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 11 (4) , 228
Abstract
We conducted untargeted metabolomics analysis of plasma samples from a cross-sectional case–control study with 30 healthy controls, 30 patients with diabetes mellitus and normal renal function (DM-N), and 30 early diabetic nephropathy (DKD) patients using liquid chromatography-mass spectrometry (LC-MS). We employed two different modes of MS acquisition on a high-resolution MS instrument for identification and semi-quantification, and analyzed data using an advanced multivariate method for prioritizing differentially abundant metabolites. We obtained semi-quantification data for 1088 unique compounds (~55% lipids), excluding compounds that may be either exogenous compounds or treated as medication. Supervised classification analysis over a confounding-free partial correlation network shows that prostaglandins, phospholipids, nucleotides, sugars, and glycans are elevated in the DM-N and DKD patients, whereas glutamine, phenylacetylglutamine, 3-indoxyl sulfate, acetylphenylalanine, xanthine, dimethyluric acid, and asymmetric dimethylarginine are increased in DKD compared to DM-N. The data recapitulate the well-established plasma metabolome changes associated with DM-N and suggest uremic solutes and oxidative stress markers as the compounds indicating early renal function decline in DM patients.Keywords
Funding Information
- Ministry of Education - Singapore (MOE2016-T2-1-001)
- National Medical Research Council (NMRC/CG/M009/2017, NMRC/OF-LCG/DYNAMO/2017, NMRC/CG/SERI/2017)
- Venerable Yen Pei - National Kidney Foundation (NKFRC/2015/07/06)
- National Research Foundation Singapore (IAF-ICP I1901E0040)
This publication has 41 references indexed in Scilit:
- Optimized Metabolomic Approach to Identify Uremic Solutes in Plasma of Stage 3–4 Chronic Kidney Disease PatientsPLOS ONE, 2013
- Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathyAnalytical and Bioanalytical Chemistry, 2012
- The plasma 5′-AMP acts as a potential upstream regulator of hyperglycemia in type 2 diabetic miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney diseaseJournal of Pharmaceutical and Biomedical Analysis, 2012
- A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitusDiabetologia, 2011
- Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)Metabolomics, 2011
- MassBank: a public repository for sharing mass spectral data for life sciencesJournal of Mass Spectrometry, 2010
- Sparse inverse covariance estimation with the graphical lassoBiostatistics, 2007
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- The positive false discovery rate: a Bayesian interpretation and the q-valueThe Annals of Statistics, 2003